Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|September 12, 2022
The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studiesDiqin Yan, Huaying Fan, Min Chen, et al.
Journal of Natural Products|November 28, 2024
Synthesis, Biological Evaluation, and Mechanistic Insights of Rubrolide Analogues as Antitumor AgentsHaoyu Wu, Guangyao Lv, Liying Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 18, 2019
The in vitro and in vivo anti-inflammatory effect of osthole, the major natural coumarin from Cnidium monnieri (L.) Cuss, via the blocking of the activation of the NF-κB and MAPK/p38 pathwaysHuaying Fan, Zhenfang Gao, Kai Ji, et al.
Clinical Pharmacology and Therapeutics|December 23, 2024
Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta-AnalysisFan Huang, Dingyuan Hu, Huaying Fan, et al.
European Journal of Pharmacology|May 27, 2019
Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathwaysXuekai Wang, Dong Qi, Fenghua Fu, et al.
Drug Delivery|February 4, 2022
Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritisCaiwei Yu, Hui Liu, Chunjing Guo, et al.
Journal of Natural Medicines|February 4, 2019
Correction to: Identification of β‑carboline and canthinone alkaloids as anti‑inflammatory agents but with different inhibitory profile on the expression of iNOS and COX‑2 in lipopolysaccharide‑activated RAW 264.7 macrophagesPan Liu, Huixiang Li, Ruiling Luan, et al.
BMJ Open|November 25, 2020
Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocolWenliang Dong, Xiaoyan Nie, Jiaxue Wang, et al.
Journal of Natural Medicines|October 17, 2018
Identification of β-carboline and canthinone alkaloids as anti-inflammatory agents but with different inhibitory profile on the expression of iNOS and COX-2 in lipopolysaccharide-activated RAW 264.7 macrophagesPan Liu, Huixiang Li, Ruiling Luan, et al.
Expert Opinion on Biological Therapy|July 8, 2021
Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trialWenliang Dong, Min Chen, Suping Niu, et al.
Pageof 8